HUM
36
2
VRSK
59
21
RSG
67
-6
EQR
62
-2
EXC
58
-2
UPS
46
-2
PRGO
64
2
MRO
40
-2
GWW
43
-12
EXR
46
6
DOW
46
2
CB
47
3
YUM
57
-9
GE
67
-3
HPE
10
-6
BLK
57
3
NI
50
2
COF
63
-2
HP
30
-3
ED
56
3
HUM
36
2
VRSK
59
21
RSG
67
-6
EQR
62
-2
EXC
58
-2
UPS
46
-2
PRGO
64
2
MRO
40
-2
GWW
43
-12
EXR
46
6
DOW
46
2
CB
47
3
YUM
57
-9
GE
67
-3
HPE
10
-6
BLK
57
3
NI
50
2
COF
63
-2
HP
30
-3
ED
56
3
Financhill
Back

Anavex Life Sciences Quote, Financials, Valuation and Earnings

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Sell
35

AVXL
Anavex Life Sciences

Last Price:
3.68
Seasonality Move:
11.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Anavex Life Sciences Price Quote

$3.68

Anavex Life Sciences Key Stats

Sell
35
Anavex Life Sciences (AVXL) is a Sell
Day range:
$3.53 - $3.85
52-week range:
$3.25 - $10.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.23%
Volume:
1M
Avg. volume:
1.2M
1-year change:
-55.23%
Market cap:
$302.2M
Revenue:
$0
EPS:
$-0.55

How Much Does Anavex Life Sciences Make?

Data Unavailable

Is Anavex Life Sciences Growing As A Company?

Data Unavailable

Anavex Life Sciences Stock Price Performance

What Is Anavex Life Sciences 52-Week High & Low?

Anavex Life Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Anavex Life Sciences?

Is Anavex Life Sciences Cash Flow Positive?

  • What Is AVXL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$29.3M
  • What Is Anavex Life Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $29.5M
  • What Is Anavex Life Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Anavex Life Sciences Return On Invested Capital

Data Unavailable

Anavex Life Sciences Earnings Date & Stock Price

Anavex Life Sciences Competitors

  • Who Are Anavex Life Sciences's Competitors?
    Below is a list of companies who compete with Anavex Life Sciences or are related in some way:
    • Checkpoint Therapeutics Inc (CKPT)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Sarepta Therapeutics Inc (SRPT)
    • Vertex Pharmaceuticals Inc (VRTX)
    • Ventyx Biosciences Inc (VTYX)

Anavex Life Sciences Dividend Yield

Data Unavailable

Anavex Life Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 26.67%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 32.50
Upside from Last Price: 783.15%

Major Shareholders

  • How many AVXL shares are owned by institutional investors?
    45.6M AVXL shares are owned by institutional investors
  • How many AVXL shares are owned by insiders?
    4.1M AVXL shares are owned by insiders